Articles | Volume 5, issue 1
J. Bone Joint Infect., 5, 16–24, 2020
https://doi.org/10.7150/jbji.40667
J. Bone Joint Infect., 5, 16–24, 2020
https://doi.org/10.7150/jbji.40667

Review 01 Jan 2020

Review | 01 Jan 2020

Oral Flucloxacillin for Treating Osteomyelitis: A Narrative Review of Clinical Practice

Helga Preiss et al.

Cited articles

Rod-Fleury T, Dunkel N, Assal M. et al. Duration of post-surgical antibiotic therapy for adult chronic osteomyelitis: a single-centre experience. Int Orthop. 2011;35:1725–31. [PMC free article]
Uçkay I, Jugun K, Gamulin A, Wagener J, Hoffmeyer P, Lew D. Chronic osteomyelitis. Curr Infect Dis Rep. 2012;14:566–75.
Gardiol C, Voumard R, Cochet C, de Vallière S. Setting up an outpatient parenteral antimicrobial therapy (OPAT) unit in Switzerland: review of the first 18 months of activity. Eur J Clin Microbiol Infect Dis. 2016;35:839–45.
Landesdorfer C, Bulitta J, Kinzig M. et al. Penetration of Antibacterials into Bone. Clin Pharmacokinet. 2009;48:89–124.
Gath J, Charles B, Sampso J, Smithurs B. Pharmacokinetics and Bioavailability of Flucloxacillin in Elderly Hospitalized Patients. J Clin Pharmacol. 1995;35:31–6.